指南与共识外周动脉疾病

法国指南:下肢外周动脉疾病日间血管腔内手术管理

French Guidelines for the Management of Ambulatory Endovascular Procedures for Lower Extremity Peripheral Artery Disease.
指南 / 共识 · Ann Vasc Surg · 2019-05-25

BACKGROUND: Ambulatory hospitalization for endovascular repair of lower extremity peripheral arterial disease (PAD) could be a real opportunity to respond to the burden of PAD, to reduce costs, and to improve patients' empowerment.…

要点

  • 日间管理资格基于患者、手术和结构三联评估,无年龄上限。
  • ASA I-III稳定患者可入选,严重肥胖、睡眠呼吸暂停、慢性肾衰竭需术前评估。
  • 危重肢体缺血和复杂病变不视为排除标准,抗血小板药物使用不视为禁忌。

核心结论

  • SCVE指南旨在规范下肢外周动脉疾病日间血管腔内手术实践,帮助血管介入医生日常操作。

主要发现

  • 日间管理资格应基于患者、手术和结构三联评估。
  • 无年龄限制推荐,ASA I、II和III稳定患者有资格接受日间干预。
  • 严重肥胖、睡眠呼吸暂停和/或慢性肾衰竭等特定合并症应术前评估。
  • 危重肢体缺血和复杂病变未被列为排除标准,抗血小板药物(阿司匹林和/或氯吡格雷)使用未被列为禁忌。
  • 推荐超声引导股动脉穿刺,7F及以下鞘管推荐手动压迫或闭合装置,经皮股动脉入路后至少需监测4小时方可离院。

关键数值与推荐

  • 无年龄限制推荐。
  • ASA I、II和III稳定患者有资格接受日间干预。
  • 7F及以下鞘管推荐手动压迫或闭合装置。
  • 经皮股动脉入路后至少监测4小时方可离院。

临床怎么用

  • 血管介入医生可依据患者、手术和结构三联评估筛选适合日间血管腔内手术的下肢PAD患者。
  • 术前应评估严重肥胖、睡眠呼吸暂停和/或慢性肾衰竭等合并症,但危重肢体缺血、复杂病变及抗血小板药物使用不构成排除理由。
  • 操作推荐超声引导股动脉穿刺,7F及以下鞘管使用手动压迫或闭合装置,术后至少监测4小时再离院。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ambulatory hospitalization for endovascular repair of lower extremity peripheral arterial disease (PAD) could be a real opportunity to respond to the burden of PAD, to reduce costs, and to improve patients' empowerment. The French Society of Vascular and Endovascular Surgery (SCVE) established guidelines to facilitate the development of ambulatory hospitalization in France. METHODS: In 2017, we used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and MEDLINE database to conduct a systematic review of available literature. A total of 448 relevant articles were found. Twelve articles, all published after the year 2000, were included and reviewed by two independent investigators. The SCVE mandated a scientific committee to collectively establish these guidelines. RESULTS: Eligibility for ambulatory management shall be based on the assessment of the triad: (1) patient, (2) procedure, and (3) structure. Comprehensive information and a detailed procedural pathway should be provided for the patient. No age limit is recommended. American Society of Anesthesiologists I, II, and III stable patients are eligible for ambulatory intervention. Specific comorbidities such as severe obesity, sleep apnea, and/or chronic kidney failure should be assessed preoperatively. Critical limb ischemia and complex lesions have not been considered as exclusion criteria. Antiplatelet drug use (aspirin and/or clopidogrel) has not been considered as a contraindication. Femoral ultrasound-guided puncture is recommended. Manual compression or closure devices have been recommended for 7F sheath or less. A minimum of 4 hours of monitoring after percutaneous femoral access is required before discharge. CONCLUSIONS: The SCVE guidelines aim to frame the practice of ambulatory endovascular procedures for lower extremity peripheral artery disease and to give vascular interventionalists help in their routine practice.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Alimi Y, Hauguel A, Casbas L, et al. French Guidelines for the Management of Ambulatory Endovascular Procedures for Lower Extremity Peripheral Artery Disease. Ann Vasc Surg. 2019. PMID: 31132446. doi:10.1016/j.avsg.2019.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。